Oriano, M.; Gramegna, A.; Amati, F.; D’Adda, A.; Gaffuri, M.; Contoli, M.; Bindo, F.; Simonetta, E.; Di Francesco, C.; Santambrogio, M.;
et al. T2-High Endotype and Response to Biological Treatments in Patients with Bronchiectasis. Biomedicines 2021, 9, 772.
https://doi.org/10.3390/biomedicines9070772
AMA Style
Oriano M, Gramegna A, Amati F, D’Adda A, Gaffuri M, Contoli M, Bindo F, Simonetta E, Di Francesco C, Santambrogio M,
et al. T2-High Endotype and Response to Biological Treatments in Patients with Bronchiectasis. Biomedicines. 2021; 9(7):772.
https://doi.org/10.3390/biomedicines9070772
Chicago/Turabian Style
Oriano, Martina, Andrea Gramegna, Francesco Amati, Alice D’Adda, Michele Gaffuri, Marco Contoli, Francesco Bindo, Edoardo Simonetta, Carlotta Di Francesco, Martina Santambrogio,
and et al. 2021. "T2-High Endotype and Response to Biological Treatments in Patients with Bronchiectasis" Biomedicines 9, no. 7: 772.
https://doi.org/10.3390/biomedicines9070772
APA Style
Oriano, M., Gramegna, A., Amati, F., D’Adda, A., Gaffuri, M., Contoli, M., Bindo, F., Simonetta, E., Di Francesco, C., Santambrogio, M., Sotgiu, G., Blasi, F., & Aliberti, S.
(2021). T2-High Endotype and Response to Biological Treatments in Patients with Bronchiectasis. Biomedicines, 9(7), 772.
https://doi.org/10.3390/biomedicines9070772